Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amedisys Inc (NQ: AMED ) 97.10 +0.09 (+0.09%) Streaming Delayed Price Updated: 12:33 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amedisys Inc < Previous 1 2 3 4 Next > Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model August 21, 2024 Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers From Amedisys, Inc. Via GlobeNewswire AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024 July 24, 2024 AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024 April 24, 2024 AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes April 23, 2024 It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. Via InvestorPlace Is NASDAQ:AMED suited for quality investing? August 14, 2023 AMEDISYS INC (NASDAQ:AMED) may be suited for quality investing, we'll explore why in this article. Via Chartmill What 11 Analyst Ratings Have To Say About Amedisys July 27, 2023 Via Benzinga Analyst Ratings for Amedisys June 27, 2023 Via Benzinga 3 Stocks To Turn $1,000 Into $10,000 in 10 Years January 12, 2024 There are a few simple rules for investing for 10x returns but they are among the most difficult to follow. Via InvestorPlace 3 Stocks Profiting from America’s Long-Term Care Crisis November 22, 2023 These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement. Via InvestorPlace Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know September 14, 2023 Via Benzinga The 3 Best Stock Picks for This Week September 05, 2023 The best stock picks for this week have long-term aims such as high earnings and growth for your portfolio. Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED) August 08, 2023 From Brodsky & Smith LLC Via GlobeNewswire Expert Ratings for Amedisys June 06, 2023 Via Benzinga Amedisys Inc. (NASDAQ: AMED) Near the Top of Equities by Percentage Gain on 6/5 June 05, 2023 Via Investor Brand Network BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED) July 28, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX) July 25, 2023 From Brodsky & Smith LLC Via GlobeNewswire Why Shares of Amedisys Are Jumping Monday June 05, 2023 The home healthcare company received a buyout offer from a segment of UnitedHealth Group. Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX) July 20, 2023 From Brodsky & Smith LLC Via GlobeNewswire Is UnitedHealth Group Stock a Buy Now? July 11, 2023 The nation's largest health insurer has seen its shares fall despite a strong start to the year. Via The Motley Fool SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED) July 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 July 06, 2023 Via Benzinga Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday July 06, 2023 Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 June 28, 2023 Via Benzinga AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders June 26, 2023 From Halper Sadeh LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 June 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023 June 06, 2023 Via Benzinga Optum's Decision To Target Amedisys Is Intriguing, Says Analyst June 05, 2023 Via Benzinga Why Shares Of Amedisys Inc Are Rising June 05, 2023 Amedisys Inc (NASDAQ: AMED) shares are up Monday after the company announced that it received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the... Via Benzinga Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 05, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.